CAR T Cell Immunotherapy for Multiple Myeloma. A Review of Current Data and Potential Clinical Applications

American Journal of Hematology - United States
doi 10.1002/ajh.25428
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Wiley

Related search

CAR T-Cell Approvals: Multiple Myeloma Likely Next Up

The Journal of Community and Supportive Oncology
2016English

Cell-Based Immunotherapy Approaches for Multiple Myeloma

British Journal of Cancer
Cancer ResearchOncology
2018English

GPRC5D CAR T-Cell Therapy Has Antitumor Activity in Multiple Myeloma

Cancer Discovery
Oncology
2019English

Targeting T Cell Malignancies Using CAR-based Immunotherapy: Challenges and Potential Solutions

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2019English

Toxicities of CD19 CAR-T Cell Immunotherapy

American Journal of Hematology
Hematology
2019English

Chimeric Antigen Receptor T Cell Targeting B Cell Maturation Antigen Immunotherapy Is Promising for Multiple Myeloma

Annals of Hematology
MedicineHematology
2019English

Current Developments in Immunotherapy in the Treatment of Multiple Myeloma

Cancer
Cancer ResearchOncology
2018English

Γδ T Cell Immunotherapy—A Review

Pharmaceuticals
Molecular MedicinePharmaceutical Science
2015English

Improving CAR T Cell Immunotherapy–mediated Remissions for Pediatric Leukemia

Journal of Clinical Investigation
Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy